Sign in

CIK 0001531177

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Sight Sciences, Inc.

Sign in to watch
Ticker
SGHT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
800625749
Phone
+1 415-889-0550
Business address
4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$652,777
in 5 filings, $653K under 10b5-1 plans

Net −$652,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-01-04 Selnick Jesse Chief Financial Officer Shares withheld for taxes −2,891 $12.38 $36K 403,359
2023-01-01 Selnick Jesse Chief Financial Officer Grant or award +28,100 406,250
2022-05-13 Selnick Jesse Chief Financial Officer Purchase +5,000 $8.28 $41K 249,225
2022-05-11 Selnick Jesse Chief Financial Officer Option exercise +120,000 $0.35 $42K 369,225
2022-05-11 Selnick Jesse Chief Financial Officer Option exercise +30,000 $0.62 $19K 399,225
2022-05-11 Selnick Jesse Chief Financial Officer Option exercise · Stock Option (Right to Buy) −120,000 0
2022-05-11 Selnick Jesse Chief Financial Officer Option exercise · Stock Option (Right to Buy) −30,000 10,000
2022-02-09 Selnick Jesse Chief Financial Officer Grant or award · Restricted Stock Units +28,100 28,100
2022-02-09 Selnick Jesse Chief Financial Officer Grant or award · Stock Option (Right to Buy) +112,400 112,400
2021-11-23 Selnick Jesse Chief Financial Officer Purchase +10,000 $18.44 $184K 2,229,568
2021-07-19 Selnick Jesse Chief Financial Officer Conversion +2,219,568 2,219,568
2021-07-19 Selnick Jesse Chief Financial Officer Conversion · Series A Redeemable Convertible Preferred Stock −869,565 0
2021-07-19 Selnick Jesse Chief Financial Officer Conversion · Series B Redeemable Convertible Preferred Stock −118,494 0
2021-07-19 Selnick Jesse Chief Financial Officer Conversion · Series C Redeemable Convertible Preferred Stock −121,725 0

Page 1 of 1 · 14 trades